BILL ANALYSIS �
-----------------------------------------------------------------
|SENATE RULES COMMITTEE | AJR 51|
|Office of Senate Floor Analyses | |
|1020 N Street, Suite 524 | |
|(916) 651-1520 Fax: (916) | |
|327-4478 | |
-----------------------------------------------------------------
THIRD READING
Bill No: AJR 51
Author: Brown (D), et al.
Amended: 8/18/14 in Assembly
Vote: 21
ASSEMBLY FLOOR : 79-0, 8/25/14 (Consent) - See last page for
vote
SUBJECT : Sickle Cell Anemia Awareness Month
SOURCE : Author
DIGEST : This resolution recognizes the month of September
2014, as Sickle Cell Anemia Awareness Month in California, and
urges Congress of the United States to support the President's
continuation of funding for sickle cell anemia centers and
research.
ANALYSIS : This resolution makes the following legislative
findings:
1.Sickle cell anemia and sickle cell disease refer to a group of
inherited disorders that affect red blood cells causing the
person's body to produce abnormally shaped red blood cells
that resemble a crescent or sickle of which do not last as
long as round blood cells, causing anemia.
2.It is estimated that more than 90,000 Americans have sickle
cell anemia; one in every 500 African Americans and one in
every 36,000 Latino births are affected.
CONTINUED
AJR 51
Page
2
3.Sickle cell anemia can be a life-threatening condition, and
access to comprehensive care can be limited by social,
economic, cultural, and geographic barriers; and the average
cost of hospitalization for sickle cell anemia in 2004 was
$6,223 and the total cost for 84,000 hospital admissions was
$488,000,000; of which 65 percent was covered by Medicaid
funds.
4.In 1972, the Sickle Cell Anemia Control Act was signed into
law by President Richard Nixon after pledging that his
administration would "reverse the record of neglect on the
dreaded disease" by increasing funding for and expanding
sickle cell anemia-related programs, including the development
of comprehensive sickle cell anemia centers.
5.A potentially groundbreaking investigational drug, GMI 1070,
designed to treat painful vaso-occlusive crises, which occur
when red blood cells lump together and impede blood flow in
sickle cell patients, has been found to be safe following
clinical trials at University of California, Davis.
This resolution recognizes the month of September 2014, as
Sickle Cell Anemia Awareness Month in California, and urges
Congress of the United States to support the President's
continuation of funding for sickle cell anemia centers and
research.
FISCAL EFFECT : Fiscal Com.: No
ASSEMBLY FLOOR : 79-0, 8/25/14
AYES: Achadjian, Alejo, Allen, Ammiano, Bigelow, Bloom,
Bocanegra, Bonilla, Bonta, Bradford, Brown, Buchanan, Ian
Calderon, Campos, Chau, Ch�vez, Chesbro, Conway, Cooley,
Dababneh, Dahle, Daly, Dickinson, Donnelly, Eggman, Fong, Fox,
Frazier, Beth Gaines, Garcia, Gatto, Gomez, Gonzalez, Gordon,
Gorell, Gray, Grove, Hagman, Hall, Harkey, Roger Hern�ndez,
Holden, Jones, Jones-Sawyer, Levine, Linder, Logue, Lowenthal,
Maienschein, Mansoor, Medina, Melendez, Mullin, Muratsuchi,
Nazarian, Nestande, Olsen, Pan, Patterson, Perea, John A.
P�rez, V. Manuel P�rez, Quirk, Quirk-Silva, Rendon,
Ridley-Thomas, Rodriguez, Salas, Skinner, Stone, Ting, Wagner,
AJR 51
Page
3
Waldron, Weber, Wieckowski, Wilk, Williams, Yamada, Atkins
NO VOTE RECORDED: Vacancy
JA:k 8/27/14 Senate Floor Analyses
SUPPORT/OPPOSITION: NONE RECEIVED
**** END ****